CSL Ltd shares down Friday, underperforms the Health Care sector
Here is the latest company close update for CSL Ltd, CSL.
Here is the latest company close update for CSL Ltd, CSL.
Interim nod for the aviation partners to operate 28 weekly return flights between Doha and Aus cities. Meta warns on incoming social media ban. Cbus chair Wayne Swan says no ‘reserve’ being built for fine payments. ANZ forecasts May rate cut.
Star investors vote against CEO pay amid liquidity, viability concerns. ACCC sues Webjet. IAG snaps up most of RACQ underwriting for $855m. AVJennings shares rocket on takeover. Activist group ordered to pay Santos $9m.
In a case challenging the veracity of Santos’ CO2 emissions reduction, the Federal Court has heard testimony from a former boss who says the company’s commitment is genuine.
CSL has argued its executive pay levels are below the global median for companies in its field, after copping a first strike against its remuneration report from shareholders.
The ASX 200 has again traded sideways on Thursday, after $48bn was wiped off the sharemarket during Tuesday’s trading.
From January 1, 2025, new rules will come into effect that will require European car manufacturers to reduce the CO2 intensity on their range of models.
PolyNovo director pockets near-$2m in selloff. ‘Misalignment’ between Labor and business risky: KPMG. Harvey Norman sued over alleged worthless warranties. Woodside sets up decade of LNG supply to Japan.
Australia’s biggest health company has a new weapon to accelerate its search to find the next blockbuster drugs in its $1bn annual research and development program.
Farmers are banding together to try and cash in on government grants for carbon trading and avoid the growing numbers of ‘carbon cowboys’ seeking to rip them off.
The annual results season is offering clear signals; Telstra and CSL are firing again but there’s no such luck for ASX, Seek or Seven Media.
CSL’s annual profit soared 25 per cent amid strong demand for its products, however a weaker than expected outlook has sent its shares sharply lower.
The ASX made a third-straight day of gains after a week of global volatility, with financial and consumer stocks pushing a marginal gain.
The homegrown drug company wants to be known as a smart manufacturer as much as for its role in helping to save lives.
Wages growth at its slowest pace in two years, but no rate cut yet. CSL’s FY25 guidance disappoints. Orora rejects Lone Star’s ‘opportunistic’ $4.3bn offer. Seek dives after swing to loss. Temple & Webster soars on trading update.
Healthcare stocks could provide a buying opportunity as the profit season rolls out, with strong fundamentals at the large end providing support for stocks such as CSL.
Clear economic danger of ideological frolics and wishful thinking.
As Melbourne plays host to energy policymakers from around the region and beyond to discuss carbon capture and storage, the prospect of regional cross-border trade in CO2 grows every day.
Guzman y Gomez to list with $2.2bn value. Telix jumps on cancer drug ‘signal’. Household savings hit fresh record. Rival offer may revive BHP’s Anglo bid: Morningstar. CSL to help US stockpile avian flu vax.
Hit with two flight cancellations on work trips recently I realised delays are unavoidable these days. Here’s what you can do about it.
Original URL: https://www.theaustralian.com.au/topics/csl